Story thread · 3 reports / 2 sources

Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds

drugs.com · 6hShare

TUESDAY, Aug. 11, 2026 — Sally Osmer jumped at the chance to be treated with the cutting-edge Alzheimer’s drug lecanemab. Osmer has a family history of the disease, and was diagnosed with early-stage Alzheimer’s at age 74. She...

First report: An Alzheimer’s Drug Cut Expected Cognitive Decline Roughly in Half. It Didn’t Target Amyloid — inc.com, 1d